Danilo Verge
Operationeel Directeur bij
Profiel
Danilo Verge is currently the Chief Operating & Medical Officer at Viewmind, Inc. He previously worked as the Head-Global Medical Affairs at Zealand Pharma A from 2020 to 2022.
Dr. Verge holds an MBA from Copenhagen Business School, an undergraduate degree from St. Lawrence University, and a doctorate from Universidad de Buenos Aires.
Laatste nieuws over Danilo Verge
Actieve functies van Danilo Verge
Bedrijven | Functie | Begin |
---|---|---|
Viewmind, Inc.
![]() Viewmind, Inc. Information Technology ServicesTechnology Services Viewmind, Inc. is a leader in precision measurement of ocular movement alterations, providing insights into brain and mental health. The company is based in New York, NY. The company's digital assessments offer high sensitivity and specificity, contributing to advancements in precision drug development and patient care. The company was founded by Gerardo Fernandez, Mark Edwards, Matias Shulz. The CEO is Mark Edwards. | Operationeel Directeur | 22-08-2023 |
Eerdere bekende functies van Danilo Verge
Bedrijven | Functie | Einde |
---|---|---|
ZEALAND PHARMA A/S | Hoofd Techniek/Wetenschap/O&O | 01-06-2022 |
Opleiding van Danilo Verge
St. Lawrence University | Undergraduate Degree |
Copenhagen Business School | Masters Business Admin |
Universidad de Buenos Aires | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ZEALAND PHARMA A/S | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Viewmind, Inc.
![]() Viewmind, Inc. Information Technology ServicesTechnology Services Viewmind, Inc. is a leader in precision measurement of ocular movement alterations, providing insights into brain and mental health. The company is based in New York, NY. The company's digital assessments offer high sensitivity and specificity, contributing to advancements in precision drug development and patient care. The company was founded by Gerardo Fernandez, Mark Edwards, Matias Shulz. The CEO is Mark Edwards. | Technology Services |